Skip to content
★ Sign in to follow
CL

Charles L. Dimmler III

Gene Logic Inc
Total declarations
28
Company
1
▲ Purchases (22 ops.)
€102k
▼ Sales (0 ops.)
—

Latest filing published 24 Mar 2008 for GENE LOGIC INC, €44k.

Insider track record

Disclosed buys
22
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
22

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Charles L. Dimmler III: trading record in brief

Charles L. Dimmler III discloses dealings in Gene Logic Inc to SEC (Form 4). Between 27 February 2007 and 21 March 2008, the trades on record add up to 28 filings.

On the market, this insider has only ever bought: 22 purchases, €102k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants.

The median purchase comes to €3,057.

The record was last updated on 24 March 2008 with a share grant (€44k) in Gene Logic Inc. The last purchase on record was published on 30 November 2007, which is 6,918 days ago. Most trades are made public on the day they happen. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Charles L. Dimmler III

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations27 total
  • ◆
    CEO & PresidentExecutivesGene Logic Inc
    68,500 USD0SEC
    50,000 shares@ US$1.37Common StockSEC:0001209191-08-019939:0
  • ◆
    CEO & PresidentExecutivesGene Logic Inc
    0SEC
    25,000 shares0Common Stock GrantSEC:0001209191-07-070540:0
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    11,562 USD0SEC
    12,300 shares@ US$0.94Common StockSEC:0001209191-07-066920:0
    Canonical exit: 28 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    2,565 USD0SEC
    2,700 shares@ US$0.9499Common StockSEC:0001209191-07-066920:1
    Canonical exit: 28 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    1,234 USD0SEC
    1,300 shares@ US$0.949Common StockSEC:0001209191-07-066920:2
    Canonical exit: 28 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    6,297 USD0SEC
    6,700 shares@ US$0.9399Common StockSEC:0001209191-07-066920:3
    Canonical exit: 28 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    758 USD0SEC
    800 shares@ US$0.948Common StockSEC:0001209191-07-066920:4
    Canonical exit: 28 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    7,790 USD0SEC
    8,200 shares@ US$0.95Common StockSEC:0001209191-07-066920:5
    Canonical exit: 28 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    8,699 USD0SEC
    9,885 shares@ US$0.88Common StockSEC:0001209191-07-066732:0
    Canonical exit: 26 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    16,928 USD0SEC
    18,400 shares@ US$0.92Common StockSEC:0001209191-07-066732:1
    Canonical exit: 27 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    3,772 USD0SEC
    4,100 shares@ US$0.9199Common StockSEC:0001209191-07-066732:2
    Canonical exit: 27 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    720 USD0SEC
    800 shares@ US$0.90Common StockSEC:0001209191-07-066732:3
    Canonical exit: 27 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    2,225 USD0SEC
    2,500 shares@ US$0.89Common StockSEC:0001209191-07-066732:4
    Canonical exit: 27 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    1,887 USD0SEC
    2,359 shares@ US$0.80Common StockSEC:0001209191-07-066213:0
    Canonical exit: 21 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    21,836 USD0SEC
    27,641 shares@ US$0.79Common StockSEC:0001209191-07-066213:1
    Canonical exit: 21 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    5,269 USD0SEC
    6,425 shares@ US$0.82Common StockSEC:0001209191-07-066213:2
    Canonical exit: 24 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    3,721 USD0SEC
    4,483 shares@ US$0.83Common StockSEC:0001209191-07-066213:3
    Canonical exit: 24 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    2,300 USD0SEC
    2,840 shares@ US$0.81Common StockSEC:0001209191-07-066213:4
    Canonical exit: 25 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    15,215 USD0SEC
    17,900 shares@ US$0.85Common StockSEC:0001209191-07-066213:5
    Canonical exit: 25 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    1,394 USD0SEC
    1,700 shares@ US$0.82Common StockSEC:0001209191-07-066213:6
    Canonical exit: 25 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    6,375 USD0SEC
    7,500 shares@ US$0.85Common StockSEC:0001209191-07-066213:7
    Canonical exit: 25 Feb 2008 (T+90)
  • ▲
    CEO & PresidentExecutivesGene Logic Inc
    48 USD0SEC
    60 shares@ US$0.805Common StockSEC:0001209191-07-066213:8
    Canonical exit: 25 Feb 2008 (T+90)
  • ◆
    CEO & PresidentExecutivesGene Logic Inc
    68,500 USD0SEC
    50,000 shares@ US$1.37Restricted StockSEC:0001209191-07-042018:0
  • ●
    CEO & PresidentExecutivesGene Logic Inc
    34,250 USD0SEC
    25,000 shares@ US$1.37Restricted StockSEC:0001209191-07-042018:1
  • ●
    CEO & PresidentExecutivesGene Logic Inc
    41,100 USD0SEC
    30,000 shares@ US$1.37Restricted StockSEC:0001209191-07-042018:2

25 of 27 declarations